IQV

NYSE IQVIA Holdings Inc

Nov 10, 2026 · 6:47 PM ET LAST TRADE Market Closed

$275.15 ↑ +0.00 (+0.00%) Trading Up from the previous close of $275.15, $2.89 below the day’s high of $278.04

YTD change: +22.07%
vs 20-day SMA: +1.99%
vs 200-day SMA: +30.79%

Price ranges

Previous day

$270.00 $279.96

open $274.00 close $278.84

+$4.84 (+1.77%)

Today

$274.10 $278.04

open $278.04 now $275.15

-$2.89 (-1.04%)

Past week

$252.38 $279.96

from $258.44 now $275.15

+$16.71 (+6.47%)

Past month

$252.38 $284.50

from $262.21 now $275.15

+$12.94 (+4.93%)

This year

$154.50 $284.50

from $225.41 now $275.15

+$49.74 (+22.07%)

Price & Performance

+105.29 (+60.67%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 3.3% away from all-time highs of $284.50
IQV is up 22% since the beginning of the year
IQV is up 29% over the past 12 months
IQV is up 5% over the past 1 month
4% of all IQV investors are betting against IQV
Number of investors short IQV has gone down 25% versus last month

IQV reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +30.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $2.81

Earnings momentum +5.6% Quarterly EPS growth

Quarterly change +5.6%

Valuation

P/E ratio 33.07

Enterprise value $46.6B

Beta 1.54

Balance sheet & scale

Income$1.2M

Revenue$15.7B

Cash$2.2B

Debt$15.7M

Income / Debt 0.08×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $46.8B

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Competitor comparison

Ticker	Company	Price	Change
REGN	Regeneron Pharmaceuticals, Inc.	$919.96	+1.73%
CRL	Charles River Laboratories International, Inc.	$353.34	+4.69%
ICLR	ICON Plc	$207.59	+1.39%
IT	Gartner, Inc.	$191.02	+0.48%
TGTX	TG Therapeutics, Inc.	$63.38	+5.94%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.